Clark Capital Management Group, Inc. Astrazeneca PLC Transaction History
Clark Capital Management Group, Inc.
- $14.3 Billion
- Q3 2024
A detailed history of Clark Capital Management Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 5,309 shares of AZN stock, worth $353,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,309
Previous 5,444
2.48%
Holding current value
$353,791
Previous $424,000
2.59%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.19 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.8 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.48 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.45 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.27 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $207B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...